The study aimed to address the practical question of whether the therapeutic benefits of cannabis extend beyond those covered by state medical programs; conditions which typically can only be treated using recreational cannabis. Due to the Schedule 1 status of cannabis and its inherent lack of product standardization, it would be difficult to design randomized controlled trials to address this important research question...... this is called the gravy train, good luck .
- Forums
- ASX - By Stock
- Proactive investor today
The study aimed to address the practical question of whether the...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
|
|||||
Last
75.5¢ |
Change
0.150(24.8%) |
Mkt cap ! $8.567M |
Open | High | Low | Value | Volume |
60.0¢ | 75.5¢ | 60.0¢ | $16.04K | 23.72K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 75.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.5¢ | 1634 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2000 | 0.755 |
1 | 146 | 0.710 |
1 | 1449 | 0.690 |
1 | 10000 | 0.630 |
1 | 943 | 0.615 |
Price($) | Vol. | No. |
---|---|---|
0.785 | 1634 | 2 |
0.790 | 3000 | 1 |
0.800 | 172 | 1 |
0.900 | 2000 | 1 |
0.960 | 6000 | 1 |
Last trade - 15.59pm 12/07/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |